Found: 13
Select item for more details and to access through your institution.
Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatments.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 6, p. 1570, doi. 10.1093/jac/dkac100
- By:
- Publication type:
- Article
Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient.
- Published in:
- Microorganisms, 2022, v. 10, n. 4, p. N.PAG, doi. 10.3390/microorganisms10040778
- By:
- Publication type:
- Article
New technologies to enhance quality and safety of table eggs: ultra-violet treatment and modified atmosphere packaging.
- Published in:
- Italian Journal of Food Safety, 2014, v. 3, n. 4, p. 192, doi. 10.4081/ijfs.2014.4462
- By:
- Publication type:
- Article
The lower respiratory tract microbiome of critically ill patients with COVID-19.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89516-6
- By:
- Publication type:
- Article
Microbiological and Modeling Approach to Derive Performance Objectives for Bacillus cereus Group in Ready-to-Eat Salads.
- Published in:
- Risk Analysis: An International Journal, 2017, v. 37, n. 3, p. 408, doi. 10.1111/risa.12617
- By:
- Publication type:
- Article
Clonal dissemination of Klebsiella pneumoniae resistant to cefiderocol, ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam co-producing KPC and OXA-181 carbapenemase.
- Published in:
- JAC-Antimicrobial Resistance, 2023, v. 5, n. 4, p. 1, doi. 10.1093/jacamr/dlad099
- By:
- Publication type:
- Article
In Vitro Evaluation of Increasing Avibactam Concentrations on Ceftazidime Activity against Ceftazidime/Avibactam-Susceptible and Resistant KPC-Producing Klebsiella pneumoniae Clinical Isolates.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 12, p. 1707, doi. 10.3390/antibiotics12121707
- By:
- Publication type:
- Article
Synergistic Activity of Cefiderocol in Combination with Piperacillin-Tazobactam, Fosfomycin, Ampicillin-Sulbactam, Imipenem-Relebactam and Ceftazidime-Avibactam against Carbapenem-Resistant Gram-Negative Bacteria.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 5, p. 858, doi. 10.3390/antibiotics12050858
- By:
- Publication type:
- Article
Comparison of Broth Microdilution, Disk Diffusion and Strip Test Methods for Cefiderocol Antimicrobial Susceptibility Testing on KPC-Producing Klebsiella pneumoniae.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 3, p. 614, doi. 10.3390/antibiotics12030614
- By:
- Publication type:
- Article
Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 5, p. 628, doi. 10.3390/antibiotics11050628
- By:
- Publication type:
- Article
Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 5, p. 536, doi. 10.3390/antibiotics10050536
- By:
- Publication type:
- Article
Corrigendum to “The STARTEC Decision Support Tool for Better Tradeoffs between Food Safety, Quality, Nutrition, and Costs in Production of Advanced Ready-to-Eat Foods”.
- Published in:
- BioMed Research International, 2018, v. 2018, p. 1, doi. 10.1155/2018/5189346
- By:
- Publication type:
- Article
The STARTEC Decision Support Tool for Better Tradeoffs between Food Safety, Quality, Nutrition, and Costs in Production of Advanced Ready-to-Eat Foods.
- Published in:
- BioMed Research International, 2017, v. 2017, p. 1, doi. 10.1155/2017/6353510
- By:
- Publication type:
- Article